Rekrutteringsfirma
Principal/ Senior Analytical Development Scientist

Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger

København N

Gå tilbage til ledige stillinger

Principal/ Senior Analytical Development Scientist

Embark on the forefront of developing a vaccine with MinervaX, where an exciting position awaits you in an international company.

https://uhc.dk/wp-content/uploads/2023/12/Faerdig-videoannonce.mp4

As Principal/ Senior Analytical Development Scientist at MinervaX, you will play a central role in developing analytical methods for MinervaX’s prophylactic vaccine targeting Group B Streptococcus (GBS).

Your main responsibilities include:

  • Manage the development, pre-validation, and validation of analytical methods to support vaccine projects.
  • Life cycle management of excising analytical methods
  • Take ownership of the stability program
  • Overseeing trending and preparing comprehensive stability reports.

Your qualifications include at least three years of experience in the pharmaceutical and/or biotechnology industry, where you have been actively working with analytical development initiatives, requiring expertise in analytical development, validation of methods, collaboration with external partners, and proficiency in ICH stability relevant to biopharmaceuticals.

You are a motivated person that is adaptable and at ease in a dynamic, collaborative, and innovative setting, You excel in balancing strategic responsibilities while remaining hands-on as required. With an energetic and passionate demeanor, you bring ambition to contribute meaningfully within a vibrant biotech organization.

MinervaX is a Danish biotechnology company, established in 2010 to develop a prophylactic vaccine against Group B Streptococcus (GBS), based on research from Lund University. MinervaX is developing a GBS vaccine for maternal immunization, likely to have superior characteristics compared with other GBS vaccine candidates in development. The latter are based on traditional capsular polysaccharide (CPS) conjugate technology. By contrast, MinervaX’s vaccine is a protein-only vaccine based on fusions of highly immunogenic and protective protein domains from selected surface proteins of GBS (the Alpha-like protein family). Given the broad distribution of proteins contained in the vaccine on GBS strains globally, it is expected that MinervaX’s vaccine will confer protection against virtually 100% of all GBS isolates.

Domicile: Commuting distance from the MinervaX office in Copenhagen.

For more details about the job or the company, please CEO Jørn Duhn, Unique Human Capital, on M: +45 21 75 19 25, [email protected]. All applications must be in English and are treated confidentially.


Information og data

Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".

Arbejdsstedet er beliggende i København N.

Jobbet er oprettet på vores service den 28.12.2023, men kan have været deaktiveret og genaktiveret igen.

Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
  • Forsker
  • København N

Lignende jobs

Statistik over udbudte jobs som forskere i København N

Herunder ser du udviklingen i udbudte forsker i København N over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.

Se flere statistikker her:
Statistik over udbudte forskere i København N over tid

Dato Alle jobs som forskere
22. november 2024 21
21. november 2024 21
20. november 2024 21
19. november 2024 19
18. november 2024 19
17. november 2024 19
16. november 2024 19
15. november 2024 20
14. november 2024 19
13. november 2024 17
12. november 2024 15
11. november 2024 17
10. november 2024 16
9. november 2024 16
8. november 2024 14
7. november 2024 15
6. november 2024 15
5. november 2024 14
4. november 2024 16
3. november 2024 16
2. november 2024 16
1. november 2024 17
31. oktober 2024 20
30. oktober 2024 20
29. oktober 2024 20
28. oktober 2024 19
27. oktober 2024 20
26. oktober 2024 20
25. oktober 2024 5
24. oktober 2024 23
23. oktober 2024 23